After-hours movers: Express gains on pulled offering, Mission Produce sinks on EPS By Investing.com

By Investing.com Staff

After-hours stock movers:

Mission Produce (NASDAQ:) 14% LOWER; reported Q4 of $0.13, $0.21 worse than the analyst estimate of $0.34. Revenue for the quarter came in at $238 million versus the consensus estimate of $247.64M.

Limoneira (NASDAQ:) 8% LOWER; reported Q4 of ($0.32), $0.21 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $39.7M versus the consensus estimate of $33.97M.

Express (NYSE:) 4% HIGHER; withdraws S-3.

Arhaus Inc (NASDAQ:) 2% LOWER; has filed for an up to 30,524,202-share offering by selling stockholders.

Mersana Therapeutics Inc (NASDAQ:) 2% HIGHER; announced a research collaboration and commercial license agreement with a subsidiary of Merck KGaA, Darmstadt, Germany to discover novel Immunosynthen ADCs directed against up to two targets. Immunosynthen, Mersanas proprietary STING-agonist ADC platform, is designed to generate systemically administered ADCs that locally activate STING signaling in both tumor-resident immune cells and in antigen-expressing tumor cells, unlocking the anti-tumor potential of innate immune stimulation.

ForgeRock Inc (NYSE:) 1% LOWER; received a request for additional information (together, the “Second Request”) from the Department of Justice (DOJ) in connection with the DOJ’s review of the merger. The issuance of the Second Request extends the waiting period under the HSR Act until 30 days after both ForgeRock and Parent have substantially complied with the Second Request, unless the waiting period is terminated earlier by the DOJ or extended by agreement of ForgeRock and Parent.